CONSORT compliance in randomized surgical trials assessing the analgesic and anti-inflammatory effectiveness of preoperative drug management of patients undergoing mandibular third molar surgery: a scoping review
- PMID: 36173725
- PMCID: PMC9648644
- DOI: 10.4317/medoral.25494
CONSORT compliance in randomized surgical trials assessing the analgesic and anti-inflammatory effectiveness of preoperative drug management of patients undergoing mandibular third molar surgery: a scoping review
Abstract
Background: Investigate methodological quality of clinical trials in mandibular third molar surgery and its compliance with the consort statement.
Material and methods: An electronic search was performed in five journal websites, chose the five scientific journals with the greatest impact factor in oral and maxillofacial surgery according to the SCImago Journal Rank. The compliance of studies with the CONSORT statement was assessed. Also, the risk of bias of each study was evaluated.
Results: Twenty-nine studies were included. The average CONSORT compliance score was 25.50 (79.68%). Most studies were performed in the Americas (n = 14, 48.3%) and Asia (n = 10, 34.5%). Parallel-group (n=15, 51.7%) and split-mouth RCTs (n=11, 38%) were the most prevalent study design. An inverse correlation was observed between the year of publication and the number of Scopus citations (p<0.001), time between acceptance and publication (p<0.001), and time between study completion and publication (p=0.040).
Conclusions: Understanding the correct use of guidelines, such as the CONSORT statement, is necessary to reduce methodological errors and possible bias, thereby ensuring reliable knowledge dissemination.
Conflict of interest statement
Conflicts of interest None of the authors of the manuscript has any conflict of interest related to this study.
Figures
References
-
- Albuquerque AFM, Fonteles CSR, do Val DR, Chaves HV, Bezerra MM, Pereira KMA. Effect of pre-emptive analgesia on clinical parameters and tissue levels of TNF-a and IL-1b in third molar surgery: a triple-blind, randomized, placebo-controlled study. Int J Oral Maxillofac Surg. 2017;46:1615–25. - PubMed
-
- Demirbas AE, Karakaya M, Bilge S, Canpolat DG, Kutuk N, Alkan A. Does Single-Dose Preemptive Intravenous Ibuprofen Reduce Postoperative Pain After Third Molar Surgery? A Prospective, Randomized, Double-Blind Clinical Study. J Oral Maxillofac Surg. 2019;77:1990–7. - PubMed
-
- Xie L, Yang RT, Lv K, Zhou HH, Li Z. Comparison of Low Pre-Emptive Oral Doses of Celecoxib Versus Acetaminophen for Postoperative Pain Management After Third Molar Surgery: A Randomized Controlled Study. J Oral Maxillofac Surg. 2020;78:75.e1–6. - PubMed
-
- Oliveira JCS, Oliveira GAG, Bassi APF. Comparative Assessment of the Effect of Ibuprofen and Etodolac on Edema, Trismus, and Pain in Lower Third Molar Surgery: A Randomized Clinical Trial. J Oral Maxillofac Surg. 2016;74:1524–30. - PubMed
-
- Isola G, Matarese M, Ramaglia L, Cicciù M, Matarese G. Evaluation of the efficacy of celecoxib and ibuprofen on postoperative pain, swelling, and mouth opening after surgical removal of impacted third molars: a randomized, controlled clinical trial. Int J Oral Maxillofac Surg. 2019;48:1348–54. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources